To view this email as a web page, click here.
 
FDA ACTIONS
 
New FDA lead ushers in new era
Scott Gottlieb, MD, was sworn in as the new FDA commissioner, ushering in an era of expected faster drug approvals.
Read more
 
Immuno-oncology bladder drug wins approval
Soon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved the immuno-oncology medication avelumab (Bavencio, EMD Serono/ Merck and Pfizer) for locally advanced or metastatic urothelial carcinoma.
Read more
 
First generic Nasonex on market
When FDA approved the first generic version of Nasonex nasal spray (mometasone furoate monohydrate) last year, the manufacturer, Apotex, was expected to profit heavily.
Find out why
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.